# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022426
Filing Date
2024-04-26
Accepted
2024-04-26 16:05:06
Documents
4
Period of Report
2024-06-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ef20027737_def14a.htm | DEF 14A | 438836
2 |  | image0.jpg | GRAPHIC | 340563
3 |  | image00001.jpg | GRAPHIC | 89322
4 |  | image00002.jpg | GRAPHIC | 102084
| Complete submission text file | 0001140361-24-022426.txt |  | 1172756

Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39580 | Film No.: 24883513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)